Hammarplast Medical AB is a pioneering company dedicated to developing, manufacturing, and assembling medical devices with a strong emphasis on environmental sustainability. With over 40 years of experience, the company operates within the realms of development, production, and global sales of large volume polymer medical disposables, as well as the design for production/assembly and contract manufacturing of complex polymer medical products. Notably, the company holds certifications for ISO 9001:2015, ISO 13485:2016, and ISO 14001: 2015, reflecting its commitment to quality and environmental management. Additionally, it adheres to the Medical Device Directive 93/42/EEC and operates in cleanroom class 7 & 8 and FDA registered facilities. Hammarplast Medical markets its brand Hpm™ within three distinct business areas: Consumables, Customized, and Transcutan. The Customized segment focuses on the contract manufacturing of medical devices for various industry sectors, while Consumables encompass branded products such as medicine measures and products for surgery and medicine distribution. The Transcutan division specializes in developing and marketing next-generation access technology solutions. Noteworthy is the company's commitment to sustainability, with a focus on producing fossil-free disposable products and increasing the utilization of renewable materials to reduce its carbon footprint. From its inception in 1990, the company has consistently demonstrated its dedication to innovation, sustainability, and quality within the Manufacturing and Medical Devices industries. Currently, there is no public information available regarding their last investment or associated investors.
There is no investment information
No recent news or press coverage available for Hammarplast Medical AB.